PHARMASYNTEZ GROUP OF COMPANIES
The Pharmasyntez Group is the leading national manufacturer of pharmaceuticals for the treatment of socially significant diseases.
- Ranked fifth on the list of the best Russian pharmaceutical companies, Forbes
- One of the top 3 fast-growing Russian technology companies, the TechUp rating
- One of the top 10 leading manufacturers by hospital procurement volume, AlphaRM
- It is included in the list of Russian systemically important companies by the Ministry of Industry and Trade of Russia
-
JSC Pharmasyntez, Irkutsk:
Antituberculosis, antitumor, antiretroviral agents, injection solutions, and hospital antibiotics. -
LLC BratskChemSyntez, Bratsk:
Active pharmaceutical ingredients of different pharmacologic classes. -
LLC EAST-PHARM, Ussuriysk:
Solutions for infusion. -
LLC Pharmasyntez-Tyumen, Tyumen:
Solutions for infusion, antidiabetic agents in solid dosage forms, hormonal drugs, and radiopaque contrast media. -
JSC Pharmasyntez-Nord, Saint Petersburg:
Antitumor agents, drug products included in the 12 High-Cost Nosologies List, Sputnik Light vaccine.
- More than 200 products of various dosage forms and pharmaceutical classes are currently manufactured at Pharmasyntez Group plants.
- The Pharmasyntez Group’s annual capacity is more than 76 mln packs.
- Export Geography: 30 pharmaceutical products of various pharmaceutical classes are exported to 10 countries (Azerbaijan, Kazakhstan, Uzbekistan, Kyrgyzstan, Belarus, Turkmenistan, Mongolia, Guinea, Romania, North Korea).
Investments
The Company is one of the largest Russian pharmaceutical industry investors. The cumulative volume of investments in projects to be completed by 2024 is over 23 bln rubles.
Pharmasyntez-Nord, Saint Petersburg
2021: Facility for research and production of biological drugs for the treatment of cancer, autoimmune diseases, and endocrine diseases.
2021: Department for the production of Gam-COVID-Vac (Sputnik Light) vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology.
Pharmasyntez-Tyumen, Tyumen
2021: Plant for hormonal drug production.
2024: Plant for production of heart disease drugs.
East-Pharm, Ussuriysk
2023: Plant for parenteral nutrition production in the Kaluga Special Economic Zone.
BratskChemSyntez, Bratsk
2023: Building for general APIs large scale production with an output of 1000 tons per year.
The company employs
over 3,500
highly skilled professionals
Innovation
There are two innovation drugs:
- Perchlozone® (INN Thioureidoiminomethylpyridinium perchlorate) for the treatment of pulmonary tuberculosis and MDR-TB. Pharmasyntez is a developer and sole manufacturer of this agent.
- Saterex® (INN Gosogliptin) for the treatment of type 2 diabetes mellitus. A full cycle production of the drug including pharmaceutical ingredient synthesis is carried out by the Company.
Drug candidate:
- Seroguard® (INN Adezmapimod) for the prevention and reduction of adhesion formation following a surgery. Phase III clinical trials are ongoing in Russia and in foreign countries.
License Agreements
- 2019 — acquisition of rights to scientific research results for the creation of a drug for the treatment and prophylaxis of tick-borne encephalitis.
- Encemab®, the Institute of Chemical Biology and Fundamental Medicine, SB RAS, Russia.
- 2020 — license agreement for the production of a drug for the treatment of orphan diseases.
- ISU305 (INN Eculizumab), ISU Abxis, South Korea.
- 2021 — commercialization of an innovative drug for leukemia.
- PF-114, Fusion Pharma, Russia, a resident of the biomedical technologies cluster of the Skolkovo Foundation.
Pharmasyntez against COVID -19
Production of large-scale batches of the drugs for the treatment of the new coronavirus infection:
- Remdeform (INN Remdesivir)
- Favibirin (INN Favipiravir)
A full cycle production including the production of Remdesivir and Favipiravir APIs is carried out at the BratskChemSyntez plant in Bratsk, Irkutsk Region, Russia.
* Included in the treatment regimen for the new coronavirus infection by the Ministry of Healthcare of the Russian Federation
Contacts
Irkutsk Office:
184, Rosa Luxemburg St., Irkutsk, Russia, 664040
Tel.: +7 3952 550355
Moscow Office:
12, Presnenskaya naberezhnaya, Federation Tower (West), 42th floor, Moscow, Russia, 123100
Tel.: +7 495 7505437